Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

IOB - Delayed Quote EUR

Fresenius Medical Care AG (0H9X.IL)

Compare

43.82

+0.03

+(0.08%)

As of 12:55:09 PM GMT. Market Open.

Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks yesterday

FME.DE
Fresenius Medical Care Full Year 2024 Earnings: EPS Misses Expectations

Fresenius Medical Care ( ETR:FME ) Full Year 2024 Results Key Financial Results Revenue: €19.3b (flat on FY 2023). Net...

Simply Wall St. 2 days ago

FMCQF

FMS
Fresenius Raises €1.1 Billion for Stake in Dialysis Company

(Bloomberg) -- Fresenius SE raised close to €1.1 billion ($1.2 billion) in a sale of shares in Fresenius Medical Care AG as well as exchangeable bonds linked to the dialysis firm, as it looks to cut debt and reallocate capital.Most Read from BloombergHow Upzoning in Cambridge Broke the YIMBY MoldRemembering the Landscape Architect Who Embraced the CityNYC Office Buildings See Resurgence as Investors Pile Into BondsHong Kong Joins Global Stadium Race With New $4 Billion Sports ParkUS Tent Facilit

Bloomberg 2 days ago

FRE.DE

FME.DE
Fresenius Sells Fresenius Medical Care Stake For $1.15 Billion

The healthcare company said it had sold 3.6% of Fresenius Medical Care’s share capital and that it would use the proceeds to help strengthen its balance sheet and reduce leverage.

The Wall Street Journal 2 days ago

FSNUF

FSNUY

FMCQF
Fresenius Medical Care (ETR:FME) Will Pay A Larger Dividend Than Last Year At €1.44

Fresenius Medical Care AG ( ETR:FME ) will increase its dividend from last year's comparable payment on the 27th of May...

Simply Wall St. 3 days ago

FMCQF

FMS
Fresenius Medical Q4 Earnings Beat Estimates, Revenues Up Y/Y

FMS' fourth-quarter results showcase a strong segmental performance along with providing full year 2025 outlook for revenue growth and operating income.

Zacks 7 days ago

FME.DE
Fresenius Medical Care AG (FMS) (Q4 2024) Earnings Call Highlights: Strong Operating Income ...

Fresenius Medical Care AG (FMS) reports robust financial results with significant improvements in operating income and strategic savings, despite challenges in the US market.

GuruFocus.com 8 days ago

FME.DE
Germany's Fresenius tops profit estimates on strong drug unit performance

German healthcare group Fresenius reported fourth-quarter earnings above market expectations on Wednesday, driven by a strong performance at its hospital drug unit Kabi. Its shares jumped around 7% by 0910 GMT, among top performers on Europe's benchmark STOXX 600 index. Since 2022, Fresenius has been reorganizing its businesses to reduce costs and liabilities, including ceding control of its former dialysis unit, Fresenius Medical Care, and exiting some other non-core operations to focus on Kabi and hospital operator Helios.

Reuters 8 days ago

FME.DE

FRE.DE
Fresenius Medical Care divests workforce by 8,200; sells Spectra assets

Fresenius Medical Care raised its 2025 savings target on the back of divested assets in 2024.

Medical Device Network 8 days ago

FME.DE

DGX
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025

"Fresenius Medical Care has again delivered against its commitments and we met the top end of our 2024 target to profitably grow our business. We successfully executed against our strategic turnaround and transformation plan, advancing our legacy portfolio optimization and realizing significant FME25 savings ahead of plan. The momentum we have created enables us to further raise our FME25 savings target from EUR 650 million to EUR 750 million", said Helen Giza, Chief Executive Officer of Freseni

PR Newswire 9 days ago

FMCQF

FMS
The Zacks Analyst Blog Highlights Fresenius Medical, Masimo, Merit Medical Systems and Inogen

Fresenius Medical, Masimo, Merit Medical Systems and Inogen are included in this Analyst Blog.

Zacks 9 days ago

MASI

INGN

MMSI
Dialysis firm FMC beats profit estimates in fourth quarter

The world's largest dialysis specialist Fresenius Medical Care topped market expectation for its fourth quarter results on Tuesday, helped by positive development across its businesses. "The momentum we have created enables us to further raise our FME25 savings target," CEO Helen Giza said in a statement. The German company's adjusted operating income grew 31% to 489 million euros ($512.3 million) in the final quarter of 2024, ahead of analysts' average estimate of 481 million euros.

Reuters 9 days ago

FME.DE
Quest to buy Fresenius Medical Care kidney testing assets

The acquisition will add dialysis-related water testing to Quest’s portfolio and position the company to perform the tests and other end-stage kidney disease services for Fresenius Medical Care.

MedTech Dive 9 days ago

FME.DE

DGX
Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

Fresenius Medical Care (XETRA: FME; NYSE: FMS), the world's leading provider of products and services for individuals with renal disease, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that, under terms of a definitive acquisition agreement, Quest will acquire select assets of FME's wholly owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the U.S.

PR Newswire 10 days ago

FMCQF

FMS

DGX
Stocks to watch this week: Berkshire Hathaway, Nvidia, Salesforce, IAG and Aston Martin

Earnings preview of key companies reporting this week and what to look out for.

Yahoo Finance UK 12 days ago

E

EIPAF

SJM
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks last month

FMS
Zacks Value Investor Highlights: Alaska Air, Heidrick & Struggles, USANA Health Sciences, General Motors and Fresenius Medical Care

Alaska Air, Heidrick & Struggles, USANA Health Sciences, General Motors and Fresenius Medical Care have been highlighted in this Value Investor article.

Zacks last month

ALK

GM

FME.DE
5 Classic Value Stocks for 2025

These stocks are cheap and have top Zacks Ranks of Strong Buy or Buy.

Zacks last month

GM

ALK

FME.DE
Fresenius Medical price target raised to $25 from $23 at Truist

Truist raised the firm’s price target on Fresenius Medical (FMS) to $25 from $23 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The firm sees the outlook for the group as “mixed”, with bullish stance on the underlying demand drivers and overarching sector tailwinds that include demographics, value-based care, and core demand being offset by heightened concern around a likely more cost focused government backdrop. Selectivity is k

TipRanks last month

FMCQF

FMS
Best Value Stocks to Buy for January 7th

FMS, SVM and CNO made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 7, 2024.

Zacks last month

FME.DE

SVM

CNO

Performance Overview

Return	0H9X.IL	DAX P
YTD	-2.01%	+16.39%
1-Year	+20.34%	+30.80%
3-Year	-12.72%	+76.97%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Fresenius Medical Care AG (0H9X.IL)

Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?

Fresenius Medical Care Full Year 2024 Earnings: EPS Misses Expectations

Fresenius Raises €1.1 Billion for Stake in Dialysis Company

Fresenius Sells Fresenius Medical Care Stake For $1.15 Billion

Fresenius Medical Care (ETR:FME) Will Pay A Larger Dividend Than Last Year At €1.44

Fresenius Medical Q4 Earnings Beat Estimates, Revenues Up Y/Y

Fresenius Medical Care AG (FMS) (Q4 2024) Earnings Call Highlights: Strong Operating Income ...

Germany's Fresenius tops profit estimates on strong drug unit performance

Fresenius Medical Care divests workforce by 8,200; sells Spectra assets

Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025

The Zacks Analyst Blog Highlights Fresenius Medical, Masimo, Merit Medical Systems and Inogen

Dialysis firm FMC beats profit estimates in fourth quarter

Quest to buy Fresenius Medical Care kidney testing assets

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

Stocks to watch this week: Berkshire Hathaway, Nvidia, Salesforce, IAG and Aston Martin

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks Value Investor Highlights: Alaska Air, Heidrick & Struggles, USANA Health Sciences, General Motors and Fresenius Medical Care

5 Classic Value Stocks for 2025

Fresenius Medical price target raised to $25 from $23 at Truist

Best Value Stocks to Buy for January 7th

Performance Overview